We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$72.6B
AUM Growth
-$484M
(-0.66%)
Cap. Flow
-$2.47B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
1,274
New
114
Increased
483
Reduced
507
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$970M |
| 2 |
Advanced Micro Devices
AMD
|
+$687M |
| 3 |
Apple
AAPL
|
+$635M |
| 4 |
Pinduoduo
PDD
|
+$630M |
| 5 |
Mercado Libre
MELI
|
+$623M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$887M |
| 2 |
Linde
LIN
|
+$715M |
| 3 |
Johnson & Johnson
JNJ
|
+$607M |
| 4 |
Tesla
TSLA
|
+$477M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$470M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.97% |
| 2 | Consumer Discretionary | 14.74% |
| 3 | Healthcare | 10.4% |
| 4 | Communication Services | 7.68% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Accuray
ARAY
$34.9M
| $169K | ﹤0.01% |
205,228
-288,499
| -58% | -$360K |
|
1127
Fate Therapeutics
FATE
$322M
| $146K | ﹤0.01% |
148,653
+2,815
| +2% | +$3.38K |
|
1128
Iovance Biotherapeutics
IOVA
$2.9B
| $128K | ﹤0.01% |
46,842
| – | – |
|
1129
Anika Therapeutics
ANIK
$277M
| $121K | ﹤0.01% |
12,635
-33,208
| -72% | -$318K |
|
1130
OraSure Technologies
OSUR
$275M
| $117K | ﹤0.01% |
48,409
| – | – |
|
1131
Ribbon Communications
RBBN
$367M
| $116K | ﹤0.01% |
40,355
-10,288
| -20% | -$33.2K |
|
1132
Commercial Vehicle Group
CVGI
$134M
| $115K | ﹤0.01% |
79,629
-590
| -0.7% | -$938 |
|
1133
Rocket Pharmaceuticals
RCKT
$397M
| $114K | ﹤0.01% |
32,515
-3,301
| -9% | -$11.3K |
|
|
TBI
1134
Trueblue
TBI
$323M
| $110K | ﹤0.01% |
24,231
-10,381
| -30% | -$53.3K |
|
1135
Harvard Bioscience
HBIO
$28.8M
| $93.1K | ﹤0.01% |
13,922
| – | – |
|
1136
DHI Group
DHX
$158M
| $70.3K | ﹤0.01% |
45,364
+12,110
| +36% | +$22.9K |
|
1137
UNIFI
UFI
$129M
| $67.9K | ﹤0.01% |
19,390
| – | – |
|
1138
Voyager Therapeutics
VYGR
$195M
| $64.4K | ﹤0.01% |
+16,381
| New | +$72.5K |
|
1139
Identive
INVE
$61.2M
| $47.3K | ﹤0.01% |
12,328
-33,157
| -73% | -$120K |
|
1140
Spero Therapeutics
SPRO
$71.2M
| $43.4K | ﹤0.01% |
18,636
-18,357
| -50% | -$42.6K |
|
1141
Culp Inc
CULP
$42.7M
| $40.9K | ﹤0.01% |
11,500
| – | – |
|
1142
Akebia Therapeutics
AKBA
$234M
| $40K | ﹤0.01% |
24,872
-401,894
| -94% | -$841K |
|
1143
Noodles & Co
NDLS
$96M
| $31.5K | ﹤0.01% |
5,579
+3,008
| +117% | +$17.1K |
|
1144
Arbutus Biopharma
ABUS
$907M
| – | – |
-26,702
| Closed | -$121K |
|
1145
AC Immune
ACIU
$232M
| – | – |
-189,892
| Closed | -$549K |
|
1146
Adaptive Biotechnologies
ADPT
$4.05B
| – | – |
-44,488
| Closed | -$666K |
|
1147
Akamai
AKAM
$16.9B
| – | – |
-10,939
| Closed | -$829K |
|
|
AL
1148
DELISTED
Air Lease Corp
AL
| – | – |
-33,935
| Closed | -$2.16M |
|
1149
Allient
ALNT
$1.92B
| – | – |
-11,067
| Closed | -$495K |
|
1150
AnaptysBio
ANAB
$1.64B
| – | – |
-839,934
| Closed | -$25.7M |
|
Similar funds
Assenagon Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Assenagon Asset Management held 1,274 positions worth $72.6B, down 0.66% from $73.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Assenagon Asset Management withdrew a net $2.47B in Q4 2025, closing 131 positions and reducing 507 holdings. Its most notable exit was Owens Corning, an estimated $69.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Assenagon Asset Management opened a new position in Kanzhun worth $62.7M.
- Assenagon Asset Management's largest Q4 2025 buy was Kanzhun: 3,076,176 shares worth $62.7M.
- Assenagon Asset Management added most to Costco in Q4 2025, an estimated $970M increase.
- Assenagon Asset Management's biggest Q4 2025 reduction was Alphabet (Google) Class C, cutting an estimated $887M.
- Assenagon Asset Management fully exited Owens Corning in Q4 2025, selling an estimated $69.2M.
- Assenagon Asset Management's ten largest holdings make up 37% of its $72.6B portfolio in Q4 2025.
- Assenagon Asset Management opened 114 new positions and closed 131 in Q4 2025.
- Assenagon Asset Management's portfolio value fell 0.66% quarter-over-quarter to $72.6B.
Based on Assenagon Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.